TWi Pharmaceuticals calls for US sanctions in Dexilant antitrust case
MLex Summary: TWi Pharmaceuticals filed a reply in support of its motion for sanctions against plaintiffs in a US antitrust suit arising from a settlement agreement between the manufacturer of protein pump...To view the full article, register now.
Already a subscriber? Click here to view full article